Erik Skullerud
Net worth: 342 $ as of 30/04/2024
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marco Renoldi | M | 67 | 8 years | |
| Per Anders Göte Samuelsson | M | 63 | 8 years | |
| Rainer Boehm | M | 63 | 4 years | |
| Pierre F. Dodion | M | 69 | - | |
| Alexander Ernst | M | 57 |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | 3 years |
| Thomas Ramdahl | M | 68 | 1 years | |
| Ragnar Linder | M | 71 |
Amgen AB
 Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | 4 years |
| Christine Wilkinson-Blanc | M | - | 1 years | |
| Kelly Constable | F | - |
Amgen AB
Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | 1 years |
| Sandra Jonsson | M | 51 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 7 | 70.00% |
| Sweden | 2 | 20.00% |
| Germany | 1 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Erik Skullerud
- Personal Network
